Inspire Medical Systems, Inc. to Report First Quarter 2022 Financial Results on May 3, 2022

Rhea-AI Summary

Inspire Medical Systems, Inc. (NYSE: INSP) will release its first-quarter 2022 financial results on May 3, after market close. Management will host a conference call at 5:00 p.m. ET to discuss these results and recent developments. Inspire specializes in innovative, minimally invasive solutions for obstructive sleep apnea, showcasing its FDA-approved neurostimulation technology as a leading treatment option. For further details, visit Inspire's website.

Positive

• Inspire has FDA approval for its proprietary neurostimulation therapy, enhancing its market position.

Negative

• No specific financial metrics or guidance provided, leaving uncertainty about performance.

MINNEAPOLIS, April 05, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the first quarter 2022 after the close of trading on Tuesday, May 3. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

Tuesday, May 3rd @ 5:00 p.m. Eastern Time:
Domestic:	(800) 344-0786
International:	(209) 905-5969
Conference ID:	5029338
Webcast:	https://edge.media-server.com/mmc/p/inp4vfpu

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989

FAQ

What date will Inspire Medical Systems release Q1 2022 financial results?

Inspire Medical Systems will release its first-quarter 2022 financial results on May 3, 2022.

What time is the conference call for Inspire's Q1 2022 financial results?

The conference call will take place at 5:00 p.m. Eastern Time on May 3, 2022.

How can I access Inspire Medical Systems' Q1 earnings call?

The earnings call can be accessed through a webcast at https://edge.media-server.com/mmc/p/inp4vfpu.

What is the main product of Inspire Medical Systems?

Inspire Medical Systems' main product is its FDA-approved neurostimulation technology for treating obstructive sleep apnea.

Is there any financial guidance provided by Inspire Medical Systems for Q1 2022?

No specific financial guidance was provided in the press release.